RU2003130644A - Производные ркарболина и их фармацевтическое применение против дипрессии и страха - Google Patents

Производные ркарболина и их фармацевтическое применение против дипрессии и страха Download PDF

Info

Publication number
RU2003130644A
RU2003130644A RU2003130644/04A RU2003130644A RU2003130644A RU 2003130644 A RU2003130644 A RU 2003130644A RU 2003130644/04 A RU2003130644/04 A RU 2003130644/04A RU 2003130644 A RU2003130644 A RU 2003130644A RU 2003130644 A RU2003130644 A RU 2003130644A
Authority
RU
Russia
Prior art keywords
acid addition
free base
addition salt
compound
alkyl
Prior art date
Application number
RU2003130644/04A
Other languages
English (en)
Russian (ru)
Inventor
Томас Й. ТРОКСЛЕР (CH)
Томас Й. ТРОКСЛЕР
Констанце ХУРТ (FR)
Констанце Хурт
Даньель УАЙЕ (FR)
Даньель УАЙЕ
Original Assignee
Новартис АГ (CH)
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис АГ (CH), Новартис Аг filed Critical Новартис АГ (CH)
Publication of RU2003130644A publication Critical patent/RU2003130644A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2003130644/04A 2001-04-03 2002-04-02 Производные ркарболина и их фармацевтическое применение против дипрессии и страха RU2003130644A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0108337.7 2001-04-03
GBGB0108337.7A GB0108337D0 (en) 2001-04-03 2001-04-03 Organic compounds

Publications (1)

Publication Number Publication Date
RU2003130644A true RU2003130644A (ru) 2005-04-10

Family

ID=9912165

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003130644/04A RU2003130644A (ru) 2001-04-03 2002-04-02 Производные ркарболина и их фармацевтическое применение против дипрессии и страха

Country Status (27)

Country Link
US (1) US6861430B2 (cg-RX-API-DMAC7.html)
EP (1) EP1377578B1 (cg-RX-API-DMAC7.html)
JP (1) JP4405732B2 (cg-RX-API-DMAC7.html)
KR (1) KR100564840B1 (cg-RX-API-DMAC7.html)
CN (1) CN1309721C (cg-RX-API-DMAC7.html)
AR (1) AR035451A1 (cg-RX-API-DMAC7.html)
AT (1) ATE517104T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002316828B2 (cg-RX-API-DMAC7.html)
BR (1) BR0208566B1 (cg-RX-API-DMAC7.html)
CA (1) CA2440014C (cg-RX-API-DMAC7.html)
CZ (1) CZ295992B6 (cg-RX-API-DMAC7.html)
EC (1) ECSP034754A (cg-RX-API-DMAC7.html)
ES (1) ES2368389T3 (cg-RX-API-DMAC7.html)
GB (1) GB0108337D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0400317A3 (cg-RX-API-DMAC7.html)
IL (1) IL157545A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03009057A (cg-RX-API-DMAC7.html)
MY (1) MY134026A (cg-RX-API-DMAC7.html)
NO (1) NO20034413D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ528370A (cg-RX-API-DMAC7.html)
PE (1) PE20021018A1 (cg-RX-API-DMAC7.html)
PL (1) PL210861B1 (cg-RX-API-DMAC7.html)
PT (1) PT1377578E (cg-RX-API-DMAC7.html)
RU (1) RU2003130644A (cg-RX-API-DMAC7.html)
SK (1) SK12222003A3 (cg-RX-API-DMAC7.html)
WO (1) WO2002081471A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200306108B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
WO2004113300A1 (ja) * 2003-06-23 2004-12-29 Ono Pharmaceutical Co., Ltd. 新規三環性複素環化合物
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
EP1829874B1 (en) 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Tricyclic compound and use thereof
WO2007062175A2 (en) * 2005-11-21 2007-05-31 Amgen Inc. Spiro-substituted tricyclic heterocycles cxcr3 antagonists
US7879859B2 (en) * 2005-11-21 2011-02-01 Merck Sharp & Dohme Corp. Diagnosis and treatment of type 2 diabetes and other disorders
EP2178537A4 (en) * 2007-07-19 2011-08-17 Merck Sharp & Dohme BETA-CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS
WO2009016329A1 (en) * 2007-07-31 2009-02-05 Cambridge Enterprise Limited Use of gabaa receptor antagonists to treat cognitive impairment in patients with psychiatric conditions
EP2300466B1 (en) 2008-06-20 2014-08-06 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
HUE026815T2 (en) 2008-11-19 2016-07-28 Forum Pharmaceuticals Inc Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
TW201028414A (en) 2009-01-16 2010-08-01 Merck Sharp & Dohme Oxadiazole beta carboline derivatives as antidiabetic compounds
EP2523558A4 (en) 2010-01-15 2013-06-19 Merck Sharp & Dohme OXADIAZOL BETA CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS
TWI519532B (zh) 2010-05-17 2016-02-01 艾維沃製藥公司 (R)-7-氯-N-(啶-3-基)苯並[b]噻吩-2-羧醯胺鹽酸鹽單水合物之結晶形體
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции
CN111349096B (zh) * 2020-04-14 2021-03-09 石河子大学 一种吲哚类化合物及其制备方法、应用
KR102467844B1 (ko) 2021-04-21 2022-11-16 삼성전자주식회사 솔리드 스테이트 드라이브 장치 및 이를 포함하는 데이터 저장 장치

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
US6057340A (en) * 1998-02-03 2000-05-02 American Home Products Corporation Oxazole derivatives as serotonin-1A receptor agonists
EP1086101B1 (en) 1998-06-12 2002-12-18 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Beta-carboline compounds

Also Published As

Publication number Publication date
PL362571A1 (en) 2004-11-02
NZ528370A (en) 2005-10-28
ATE517104T1 (de) 2011-08-15
CZ20032655A3 (cs) 2003-12-17
BR0208566A (pt) 2004-03-30
NO20034413L (no) 2003-10-02
ECSP034754A (es) 2003-10-28
WO2002081471A1 (en) 2002-10-17
PE20021018A1 (es) 2003-01-13
HUP0400317A3 (en) 2007-10-29
EP1377578A1 (en) 2004-01-07
ES2368389T3 (es) 2011-11-16
JP2004525178A (ja) 2004-08-19
JP4405732B2 (ja) 2010-01-27
ZA200306108B (en) 2004-07-05
IL157545A0 (en) 2004-03-28
US6861430B2 (en) 2005-03-01
US20040132735A1 (en) 2004-07-08
CN1309721C (zh) 2007-04-11
NO20034413D0 (no) 2003-10-02
GB0108337D0 (en) 2001-05-23
AR035451A1 (es) 2004-05-26
SK12222003A3 (sk) 2004-06-08
HUP0400317A2 (hu) 2004-09-28
EP1377578B1 (en) 2011-07-20
KR20040008150A (ko) 2004-01-28
KR100564840B1 (ko) 2006-03-28
AU2002316828B2 (en) 2006-05-11
CZ295992B6 (cs) 2005-12-14
CA2440014A1 (en) 2002-10-17
PT1377578E (pt) 2011-09-23
PL210861B1 (pl) 2012-03-30
CA2440014C (en) 2010-11-23
BR0208566B1 (pt) 2013-12-24
CN1500090A (zh) 2004-05-26
MXPA03009057A (es) 2004-02-12
MY134026A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
RU2324684C2 (ru) Пиримидиновые производные
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
RU2002123350A (ru) Дипептиднитрильные ингибиторы катепсина К
JP2007529421A5 (cg-RX-API-DMAC7.html)
RU2004110055A (ru) Новые ингибиторы дипептидил пептидазы iv в качестве антидиабетических агентов
JP2004517843A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
RU2000113729A (ru) Гетероциклические соединения для ингибирования секреции желудочной кислоты, способы их получения и их фармацевтические компоозиции
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
RU2008119692A (ru) Новые 1-азабициклоалкилпроизводные для лечения психических растройств
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
CA2440014A1 (en) Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
JP2004525178A5 (cg-RX-API-DMAC7.html)
RU2394031C2 (ru) Соли четвертичного аммония в качестве антагонистов м3
JP2020534374A5 (cg-RX-API-DMAC7.html)
JP2005516898A5 (cg-RX-API-DMAC7.html)
RU2008136762A (ru) Циклические сульфоны как ингибиторы васе
RU2004139122A (ru) Производные n-бензоилуреидокоричной кислоты, способ их получения и их применение
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
JP2003513075A5 (cg-RX-API-DMAC7.html)
RU2004107847A (ru) Изоксазолпиридиноны и их применение в лечении болезни паркинсона
RU97115107A (ru) Бициклические производные изотиомочевины, применяемые в терапии
RU2004102398A (ru) Производные бензо[g]хинолина для лечения глаукомы и близорукости
JP2003531196A5 (cg-RX-API-DMAC7.html)
RU2004110036A (ru) Глицин-замещенные тиено[2,3-d]пиримидины с объединенной lh и fsh агонистической активностью

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20070201